# Outcome of endoscopic transsphenoidal surgery for acromegaly: Comparison of using and not using the floor standing pneumatic powered endoscope-holder system

**Authors:** Masahiko Tosaka, Rei Yamaguchi, Kazuhiko Horiguchi, Atsushi Ozawa, Shunichi Matsumoto, Fumiaki Honda, Yohei Hokama, Takaaki Yoshida, Mitsuko Okano, Akihiro Tsukada, Shogo Ishiuchi, Masanobu Yamada, Yuhei Yoshimoto

PMC · DOI: 10.1016/j.heliyon.2024.e35647 · 2024-08-02

## TL;DR

This study compares surgical outcomes for acromegaly using two endoscopic techniques and finds similar remission rates, with preoperative factors predicting success.

## Contribution

The study evaluates the effectiveness of a single-surgeon endoscope-holder system in acromegaly surgery compared to a two-surgeon approach.

## Key findings

- Remission rates were 65.0% for PE/2S and 82.4% for PE/1S+H, with no significant difference.
- Low preoperative GH levels and lower Knosp grades predict better surgical outcomes.
- Revised Knosp grading showed higher sensitivity but lower specificity compared to conventional grading.

## Abstract

Endoscopic transsphenoidal surgery can be performed by two surgeons, including an endoscopist (PE/2S), and by a single surgeon with an endoscope-holder system (PE/1S + H). We analyzed the surgical outcome, and outcome predictors in acromegaly patients in endoscopic transsphenoidal surgery using floor standing pneumatic endoscope-holder system.

Endoscopic transsphenoidal surgery was performed with PE/1S+H (n = 51) and PE/2S (n = 20). Postoperative remission was evaluated by the 2010 consensus criteria for acromegaly. We compared the surgical results of PE/2S style and PE/1S+H style, and investigated the factors associated with favorable surgical outcomes.

There was no difference in clinical background between the PE/2S and the PE/1S + H groups. The remission rates for PE/2S and PE/1S+H were 65.0% and 82.4%, respectively, with no significant difference (p = 0.128). In consecutive 71 cases, statistically useful predictors of remission were low preoperative growth hormone (GH) level (<12 ng/mL), low Knosp grade (0–2), and low revised Knosp grade (0–3A). In the conventional Knosp grade 0–2 and 3/4, the sensitivity was 0.76 and the specificity was 0.81. In the revised Knosp grade 0–3A and 3B/4, the sensitivity was 0.96 and the specificity was 0.44.

The outcome of GH-producing pituitary neuroendocrine tumors surgically removed by PE/1S+H could be almost equivalent to that by PE/2S. Preoperative low GH level and Knosp grades, including revised Knosp grades, are useful preoperative predictors for surgical remission of acromegaly.

## Linked entities

- **Diseases:** acromegaly (MONDO:0019933)

## Full-text entities

- **Genes:** GH1 (growth hormone 1) [NCBI Gene 2688] {aka GH, GH-N, GHB5, GHN, IGHD1A, IGHD1B}
- **Diseases:** acromegaly (MESH:D000172), pituitary neuroendocrine tumors (MESH:D018358)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11336817/full.md

---
Source: https://tomesphere.com/paper/PMC11336817